| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Defects, Congenital | 66 | 2024 | 4671 | 5.380 |
Why?
|
| Cardiac Surgical Procedures | 45 | 2024 | 3627 | 4.880 |
Why?
|
| Fontan Procedure | 15 | 2022 | 796 | 2.510 |
Why?
|
| Cardiopulmonary Bypass | 23 | 2021 | 1092 | 2.320 |
Why?
|
| Thrombelastography | 7 | 2021 | 187 | 2.130 |
Why?
|
| Oximetry | 9 | 2020 | 459 | 2.050 |
Why?
|
| Anesthesia | 16 | 2022 | 1595 | 1.910 |
Why?
|
| Surgical Procedures, Operative | 14 | 2024 | 1924 | 1.810 |
Why?
|
| Erythrocyte Transfusion | 7 | 2022 | 570 | 1.670 |
Why?
|
| Postoperative Complications | 28 | 2023 | 15633 | 1.660 |
Why?
|
| Perioperative Care | 11 | 2024 | 1036 | 1.490 |
Why?
|
| Hypnotics and Sedatives | 9 | 2024 | 1179 | 1.480 |
Why?
|
| Conscious Sedation | 8 | 2024 | 532 | 1.430 |
Why?
|
| Oxygen | 20 | 2019 | 4227 | 1.410 |
Why?
|
| Hirudins | 4 | 2024 | 179 | 1.320 |
Why?
|
| Pediatrics | 11 | 2022 | 3589 | 1.250 |
Why?
|
| Hypoplastic Left Heart Syndrome | 7 | 2022 | 594 | 1.240 |
Why?
|
| Anesthetics | 5 | 2023 | 523 | 1.240 |
Why?
|
| Child | 102 | 2024 | 80158 | 1.230 |
Why?
|
| Hemodynamics | 15 | 2024 | 4160 | 1.230 |
Why?
|
| Milrinone | 4 | 2021 | 86 | 1.210 |
Why?
|
| Anesthesia, General | 9 | 2022 | 1174 | 1.170 |
Why?
|
| Thoracic Surgery | 3 | 2022 | 722 | 1.140 |
Why?
|
| Infant | 80 | 2024 | 36193 | 1.130 |
Why?
|
| Body Temperature | 2 | 2024 | 781 | 1.120 |
Why?
|
| Hospital Mortality | 15 | 2022 | 5293 | 1.050 |
Why?
|
| Oxyhemoglobins | 6 | 2020 | 211 | 1.030 |
Why?
|
| Echocardiography | 9 | 2024 | 4989 | 1.010 |
Why?
|
| Infant, Newborn | 61 | 2024 | 26202 | 0.980 |
Why?
|
| Pulmonary Circulation | 6 | 2019 | 737 | 0.980 |
Why?
|
| Blood Loss, Surgical | 6 | 2018 | 638 | 0.940 |
Why?
|
| Cardiac Output | 8 | 2019 | 831 | 0.930 |
Why?
|
| Blood Transfusion | 10 | 2019 | 1301 | 0.920 |
Why?
|
| Fibrinogen | 3 | 2016 | 888 | 0.870 |
Why?
|
| Neuromuscular Blockade | 2 | 2016 | 147 | 0.860 |
Why?
|
| Child, Preschool | 66 | 2024 | 42232 | 0.850 |
Why?
|
| Extracorporeal Membrane Oxygenation | 8 | 2019 | 1462 | 0.850 |
Why?
|
| Analgesia | 3 | 2016 | 461 | 0.830 |
Why?
|
| Heparin | 3 | 2024 | 1634 | 0.810 |
Why?
|
| Anesthesiology | 4 | 2022 | 1120 | 0.810 |
Why?
|
| Hospital Costs | 3 | 2017 | 947 | 0.780 |
Why?
|
| Protein-Losing Enteropathies | 1 | 2021 | 45 | 0.770 |
Why?
|
| Humans | 203 | 2024 | 761596 | 0.750 |
Why?
|
| Spectroscopy, Near-Infrared | 5 | 2020 | 740 | 0.730 |
Why?
|
| Bronchitis | 1 | 2021 | 196 | 0.720 |
Why?
|
| Midazolam | 2 | 2021 | 266 | 0.720 |
Why?
|
| Hydrogen | 1 | 2021 | 172 | 0.720 |
Why?
|
| Hematocrit | 4 | 2017 | 623 | 0.710 |
Why?
|
| Dexmedetomidine | 3 | 2010 | 319 | 0.710 |
Why?
|
| Databases, Factual | 15 | 2024 | 7968 | 0.700 |
Why?
|
| Factor VIIa | 2 | 2019 | 103 | 0.690 |
Why?
|
| Hyperoxia | 2 | 2019 | 258 | 0.690 |
Why?
|
| Heart Bypass, Right | 3 | 2018 | 75 | 0.680 |
Why?
|
| Professional Practice | 1 | 2022 | 313 | 0.680 |
Why?
|
| Heart Ventricles | 9 | 2022 | 3807 | 0.680 |
Why?
|
| Lymphatic Diseases | 1 | 2021 | 320 | 0.670 |
Why?
|
| Hemostasis | 2 | 2021 | 467 | 0.660 |
Why?
|
| Critical Care | 7 | 2022 | 2697 | 0.650 |
Why?
|
| Pulmonary Veno-Occlusive Disease | 1 | 2019 | 64 | 0.650 |
Why?
|
| Thrombosis | 8 | 2019 | 2942 | 0.640 |
Why?
|
| Anemia | 3 | 2017 | 1509 | 0.630 |
Why?
|
| Adsorption | 1 | 2019 | 197 | 0.630 |
Why?
|
| Echocardiography, Transesophageal | 7 | 2018 | 1086 | 0.620 |
Why?
|
| Ductus Arteriosus, Patent | 3 | 2023 | 217 | 0.610 |
Why?
|
| Surgical Mesh | 1 | 2021 | 311 | 0.610 |
Why?
|
| Pleural Effusion | 1 | 2021 | 341 | 0.600 |
Why?
|
| Williams Syndrome | 2 | 2018 | 194 | 0.580 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2023 | 829 | 0.580 |
Why?
|
| Heart-Assist Devices | 4 | 2019 | 1287 | 0.560 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2024 | 846 | 0.560 |
Why?
|
| Analgesics | 3 | 2019 | 1070 | 0.550 |
Why?
|
| Preoperative Care | 6 | 2021 | 2242 | 0.540 |
Why?
|
| Acute Kidney Injury | 2 | 2021 | 1924 | 0.540 |
Why?
|
| Craniosynostoses | 3 | 2016 | 412 | 0.520 |
Why?
|
| Oxygen Consumption | 6 | 2018 | 1866 | 0.510 |
Why?
|
| Tranexamic Acid | 2 | 2015 | 176 | 0.510 |
Why?
|
| Neuromuscular Blocking Agents | 2 | 2016 | 129 | 0.510 |
Why?
|
| Heart Arrest | 6 | 2022 | 1514 | 0.500 |
Why?
|
| Vulnerable Populations | 1 | 2021 | 703 | 0.490 |
Why?
|
| Antifibrinolytic Agents | 2 | 2015 | 292 | 0.480 |
Why?
|
| Intraoperative Complications | 3 | 2018 | 1166 | 0.480 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2019 | 350 | 0.480 |
Why?
|
| Operating Rooms | 3 | 2022 | 789 | 0.480 |
Why?
|
| Anesthesia, Caudal | 1 | 2015 | 33 | 0.480 |
Why?
|
| Reading | 1 | 2018 | 531 | 0.470 |
Why?
|
| Mitral Valve Insufficiency | 3 | 2018 | 1400 | 0.460 |
Why?
|
| Retrospective Studies | 53 | 2023 | 80647 | 0.460 |
Why?
|
| Heart | 9 | 2021 | 4404 | 0.450 |
Why?
|
| Hospitals, Pediatric | 9 | 2021 | 1860 | 0.450 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2023 | 1228 | 0.450 |
Why?
|
| Coronary Circulation | 4 | 2016 | 1569 | 0.440 |
Why?
|
| Hospitalization | 6 | 2023 | 10721 | 0.440 |
Why?
|
| Pulmonary Veins | 1 | 2019 | 743 | 0.440 |
Why?
|
| Heart Septal Defects, Atrial | 2 | 2016 | 451 | 0.430 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2018 | 464 | 0.430 |
Why?
|
| Heart Failure | 4 | 2023 | 11671 | 0.420 |
Why?
|
| Pulmonary Atresia | 2 | 2017 | 159 | 0.420 |
Why?
|
| Blood Gas Analysis | 3 | 2019 | 379 | 0.420 |
Why?
|
| Male | 94 | 2024 | 360846 | 0.410 |
Why?
|
| Pain, Postoperative | 3 | 2021 | 1740 | 0.410 |
Why?
|
| Bradycardia | 3 | 2009 | 299 | 0.400 |
Why?
|
| Blood Coagulation | 5 | 2021 | 1154 | 0.400 |
Why?
|
| Inpatients | 3 | 2023 | 2548 | 0.400 |
Why?
|
| Adjuvants, Anesthesia | 2 | 2009 | 58 | 0.400 |
Why?
|
| Heart Transplantation | 4 | 2016 | 3233 | 0.390 |
Why?
|
| Incidence | 18 | 2021 | 21355 | 0.390 |
Why?
|
| Length of Stay | 10 | 2022 | 6426 | 0.390 |
Why?
|
| Pulmonary Artery | 7 | 2020 | 1927 | 0.390 |
Why?
|
| Vasodilator Agents | 1 | 2016 | 973 | 0.380 |
Why?
|
| Female | 89 | 2024 | 392705 | 0.370 |
Why?
|
| Societies, Medical | 3 | 2018 | 3905 | 0.370 |
Why?
|
| Goals | 1 | 2016 | 711 | 0.370 |
Why?
|
| Hypothermia, Induced | 3 | 2015 | 753 | 0.370 |
Why?
|
| Respiration, Artificial | 4 | 2018 | 2630 | 0.350 |
Why?
|
| Treatment Outcome | 33 | 2024 | 64685 | 0.350 |
Why?
|
| Consensus | 3 | 2023 | 3124 | 0.350 |
Why?
|
| Recombinant Proteins | 6 | 2024 | 6534 | 0.330 |
Why?
|
| Glycopyrrolate | 1 | 2009 | 32 | 0.330 |
Why?
|
| Catheterization, Central Venous | 3 | 2019 | 526 | 0.320 |
Why?
|
| Hemostasis, Surgical | 1 | 2009 | 126 | 0.320 |
Why?
|
| Aortic Stenosis, Supravalvular | 1 | 2008 | 28 | 0.320 |
Why?
|
| Risk Factors | 29 | 2023 | 74213 | 0.320 |
Why?
|
| Heart Valve Prosthesis Implantation | 2 | 2018 | 1553 | 0.310 |
Why?
|
| Adolescent | 42 | 2023 | 88326 | 0.310 |
Why?
|
| Models, Theoretical | 3 | 2017 | 3575 | 0.310 |
Why?
|
| Peptide Fragments | 4 | 2024 | 5112 | 0.310 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 2009 | 214 | 0.300 |
Why?
|
| Equipment Design | 5 | 2021 | 3511 | 0.300 |
Why?
|
| Phenoxybenzamine | 1 | 2007 | 53 | 0.300 |
Why?
|
| Jugular Veins | 2 | 2017 | 210 | 0.290 |
Why?
|
| Heart Septum | 1 | 2008 | 301 | 0.290 |
Why?
|
| Head-Down Tilt | 1 | 2007 | 65 | 0.290 |
Why?
|
| Quality Improvement | 4 | 2019 | 3802 | 0.290 |
Why?
|
| Nervous System | 1 | 2010 | 545 | 0.290 |
Why?
|
| Valsalva Maneuver | 1 | 2007 | 99 | 0.290 |
Why?
|
| Postoperative Period | 5 | 2020 | 1814 | 0.280 |
Why?
|
| Postoperative Nausea and Vomiting | 2 | 2020 | 128 | 0.280 |
Why?
|
| Pain | 3 | 2018 | 5073 | 0.280 |
Why?
|
| Transposition of Great Vessels | 2 | 2022 | 581 | 0.280 |
Why?
|
| Risk Assessment | 18 | 2023 | 23996 | 0.280 |
Why?
|
| Aortic Coarctation | 2 | 2023 | 275 | 0.270 |
Why?
|
| Atrial Function, Left | 1 | 2008 | 185 | 0.270 |
Why?
|
| Anticoagulants | 4 | 2024 | 4812 | 0.270 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2017 | 2118 | 0.270 |
Why?
|
| Antithrombins | 2 | 2019 | 294 | 0.270 |
Why?
|
| Nursing Staff, Hospital | 1 | 2009 | 348 | 0.260 |
Why?
|
| Hypertension, Pulmonary | 4 | 2022 | 1578 | 0.260 |
Why?
|
| Ventricular Function | 3 | 2018 | 406 | 0.260 |
Why?
|
| Platelet Activation | 1 | 2009 | 645 | 0.250 |
Why?
|
| Education, Medical, Graduate | 1 | 2018 | 2373 | 0.250 |
Why?
|
| Intensive Care Units, Pediatric | 3 | 2018 | 1017 | 0.250 |
Why?
|
| Healthcare Disparities | 1 | 2021 | 3358 | 0.250 |
Why?
|
| Coronary Care Units | 2 | 2016 | 235 | 0.230 |
Why?
|
| Protamines | 2 | 2018 | 112 | 0.230 |
Why?
|
| Biomedical Research | 1 | 2020 | 3429 | 0.230 |
Why?
|
| Catheterization, Swan-Ganz | 1 | 2004 | 86 | 0.230 |
Why?
|
| Ventricular Fibrillation | 1 | 2007 | 537 | 0.230 |
Why?
|
| Anesthetics, Inhalation | 3 | 2018 | 574 | 0.230 |
Why?
|
| Thrombocytopenia | 2 | 2009 | 1182 | 0.220 |
Why?
|
| Palliative Care | 5 | 2017 | 3598 | 0.220 |
Why?
|
| Cerebrovascular Circulation | 5 | 2019 | 2727 | 0.220 |
Why?
|
| Coronary Vessel Anomalies | 1 | 2007 | 307 | 0.220 |
Why?
|
| Blood Preservation | 2 | 2018 | 169 | 0.220 |
Why?
|
| Medication Errors | 1 | 2009 | 783 | 0.220 |
Why?
|
| Survival Rate | 7 | 2021 | 12723 | 0.220 |
Why?
|
| Mitral Valve | 2 | 2018 | 1465 | 0.220 |
Why?
|
| Coronary Artery Bypass | 1 | 2012 | 2188 | 0.210 |
Why?
|
| Death, Sudden, Cardiac | 2 | 2022 | 1555 | 0.210 |
Why?
|
| Perioperative Period | 3 | 2020 | 250 | 0.200 |
Why?
|
| Health Care Costs | 1 | 2015 | 3242 | 0.200 |
Why?
|
| Reoperation | 5 | 2022 | 4303 | 0.200 |
Why?
|
| Clinical Competence | 1 | 2018 | 4793 | 0.200 |
Why?
|
| Postoperative Hemorrhage | 3 | 2018 | 415 | 0.200 |
Why?
|
| Stroke Volume | 1 | 2016 | 5496 | 0.190 |
Why?
|
| Isoflurane | 4 | 2021 | 384 | 0.190 |
Why?
|
| Lung | 3 | 2018 | 10002 | 0.190 |
Why?
|
| Erythrocytes | 2 | 2022 | 2413 | 0.190 |
Why?
|
| Infant, Premature | 2 | 2021 | 2107 | 0.180 |
Why?
|
| Cardiopulmonary Resuscitation | 3 | 2019 | 993 | 0.180 |
Why?
|
| Stethoscopes | 1 | 2021 | 30 | 0.180 |
Why?
|
| Atrial Septum | 1 | 2021 | 60 | 0.180 |
Why?
|
| Hemorrhage | 3 | 2021 | 3424 | 0.180 |
Why?
|
| Drug and Narcotic Control | 1 | 2001 | 144 | 0.180 |
Why?
|
| United States | 12 | 2023 | 72340 | 0.180 |
Why?
|
| Cardiac Output, Low | 1 | 2021 | 191 | 0.170 |
Why?
|
| Hypertension | 3 | 2010 | 8540 | 0.170 |
Why?
|
| Hypoxia, Brain | 1 | 2020 | 138 | 0.170 |
Why?
|
| Models, Biological | 2 | 2019 | 9469 | 0.170 |
Why?
|
| Lymphatic System | 1 | 2021 | 254 | 0.170 |
Why?
|
| Child Development | 2 | 2010 | 2306 | 0.170 |
Why?
|
| Fentanyl | 2 | 2021 | 434 | 0.170 |
Why?
|
| Cardiac Imaging Techniques | 1 | 2022 | 267 | 0.170 |
Why?
|
| Severity of Illness Index | 2 | 2016 | 15843 | 0.160 |
Why?
|
| Thermodilution | 1 | 2019 | 50 | 0.160 |
Why?
|
| Heart Valve Prosthesis | 1 | 2008 | 1462 | 0.160 |
Why?
|
| Thrombophilia | 2 | 2017 | 305 | 0.160 |
Why?
|
| Circulatory Arrest, Deep Hypothermia Induced | 2 | 2017 | 82 | 0.160 |
Why?
|
| Blood Coagulation Factors | 4 | 2007 | 365 | 0.160 |
Why?
|
| Multiple Organ Failure | 1 | 2021 | 387 | 0.160 |
Why?
|
| Magnetic Resonance Imaging | 7 | 2019 | 36426 | 0.160 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2017 | 2751 | 0.160 |
Why?
|
| Monitoring, Intraoperative | 3 | 2010 | 942 | 0.150 |
Why?
|
| Blood Platelets | 1 | 2009 | 2479 | 0.150 |
Why?
|
| Massage | 1 | 2018 | 86 | 0.150 |
Why?
|
| Platelet Transfusion | 2 | 2018 | 298 | 0.150 |
Why?
|
| Respiratory Dead Space | 1 | 2018 | 31 | 0.150 |
Why?
|
| Adult | 27 | 2023 | 221210 | 0.150 |
Why?
|
| Embolism, Air | 2 | 2016 | 110 | 0.150 |
Why?
|
| Thyroid Diseases | 1 | 2021 | 386 | 0.150 |
Why?
|
| Blood Transfusion, Autologous | 1 | 2018 | 130 | 0.150 |
Why?
|
| Marijuana Abuse | 1 | 2001 | 411 | 0.140 |
Why?
|
| Tachycardia | 1 | 2020 | 600 | 0.140 |
Why?
|
| Sternotomy | 1 | 2018 | 128 | 0.140 |
Why?
|
| Heart Function Tests | 2 | 2016 | 318 | 0.140 |
Why?
|
| Cyanosis | 1 | 2017 | 82 | 0.140 |
Why?
|
| Heart Diseases | 2 | 2021 | 2781 | 0.140 |
Why?
|
| Cardiology | 2 | 2020 | 1656 | 0.140 |
Why?
|
| Pulmonary Valve | 2 | 2004 | 411 | 0.140 |
Why?
|
| Phosphodiesterase 3 Inhibitors | 1 | 2016 | 11 | 0.140 |
Why?
|
| Vocal Cord Paralysis | 1 | 2020 | 272 | 0.140 |
Why?
|
| Peritoneal Cavity | 1 | 2017 | 135 | 0.140 |
Why?
|
| Models, Statistical | 5 | 2020 | 5079 | 0.140 |
Why?
|
| Infusions, Intravenous | 4 | 2010 | 2217 | 0.140 |
Why?
|
| Age Factors | 8 | 2020 | 18399 | 0.130 |
Why?
|
| Catheters, Indwelling | 1 | 2019 | 426 | 0.130 |
Why?
|
| California | 1 | 2020 | 1430 | 0.130 |
Why?
|
| Collateral Circulation | 1 | 2017 | 294 | 0.130 |
Why?
|
| Macrophage-1 Antigen | 1 | 2017 | 285 | 0.130 |
Why?
|
| Propensity Score | 3 | 2021 | 1913 | 0.130 |
Why?
|
| Myocardial Contraction | 3 | 2016 | 1515 | 0.130 |
Why?
|
| Hospital Charges | 2 | 2015 | 350 | 0.130 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 1 | 2017 | 377 | 0.130 |
Why?
|
| Constriction, Pathologic | 1 | 2019 | 1096 | 0.130 |
Why?
|
| Career Choice | 1 | 2022 | 756 | 0.130 |
Why?
|
| Protein-Energy Malnutrition | 1 | 1996 | 189 | 0.130 |
Why?
|
| Platelet Function Tests | 1 | 2017 | 271 | 0.120 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2017 | 10766 | 0.120 |
Why?
|
| Catheterization, Peripheral | 1 | 2019 | 343 | 0.120 |
Why?
|
| Respiration Disorders | 1 | 2018 | 367 | 0.120 |
Why?
|
| Anesthetics, Intravenous | 1 | 2018 | 395 | 0.120 |
Why?
|
| Aprotinin | 1 | 2015 | 94 | 0.120 |
Why?
|
| Neonatal Screening | 1 | 2019 | 597 | 0.120 |
Why?
|
| Monitoring, Physiologic | 4 | 2019 | 1779 | 0.120 |
Why?
|
| Child Nutrition Disorders | 1 | 1996 | 151 | 0.120 |
Why?
|
| Predictive Value of Tests | 8 | 2020 | 15266 | 0.120 |
Why?
|
| Comorbidity | 5 | 2020 | 10508 | 0.120 |
Why?
|
| Brain | 5 | 2020 | 27121 | 0.120 |
Why?
|
| Intraoperative Care | 1 | 2018 | 767 | 0.120 |
Why?
|
| Propanolamines | 1 | 1995 | 163 | 0.120 |
Why?
|
| Follow-Up Studies | 7 | 2021 | 39106 | 0.120 |
Why?
|
| Vasoconstrictor Agents | 1 | 2018 | 654 | 0.120 |
Why?
|
| Vena Cava, Inferior | 1 | 2017 | 458 | 0.120 |
Why?
|
| Fibrinolysis | 1 | 2015 | 332 | 0.110 |
Why?
|
| Physical Examination | 1 | 2020 | 1255 | 0.110 |
Why?
|
| Current Procedural Terminology | 1 | 2014 | 89 | 0.110 |
Why?
|
| Intubation, Intratracheal | 1 | 2021 | 1333 | 0.110 |
Why?
|
| Risk Adjustment | 1 | 2017 | 600 | 0.110 |
Why?
|
| Pulmonary Ventilation | 1 | 2015 | 372 | 0.110 |
Why?
|
| Disease Management | 1 | 2024 | 2508 | 0.110 |
Why?
|
| Logistic Models | 7 | 2018 | 13255 | 0.110 |
Why?
|
| Hemodilution | 2 | 2010 | 120 | 0.110 |
Why?
|
| Aortic Valve | 3 | 2004 | 1955 | 0.110 |
Why?
|
| Down Syndrome | 1 | 2021 | 901 | 0.110 |
Why?
|
| Cardiotonic Agents | 1 | 2016 | 539 | 0.110 |
Why?
|
| Adolescent Behavior | 1 | 2001 | 1190 | 0.110 |
Why?
|
| Multivariate Analysis | 5 | 2017 | 12059 | 0.110 |
Why?
|
| Defibrillators, Implantable | 1 | 2022 | 1490 | 0.100 |
Why?
|
| Aortic Valve Stenosis | 4 | 2019 | 2001 | 0.100 |
Why?
|
| Boston | 4 | 2018 | 9327 | 0.100 |
Why?
|
| Echocardiography, Three-Dimensional | 1 | 2018 | 607 | 0.100 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2020 | 942 | 0.100 |
Why?
|
| Decision Support Techniques | 2 | 2019 | 1998 | 0.100 |
Why?
|
| Parasympathetic Nervous System | 1 | 2012 | 142 | 0.100 |
Why?
|
| Blood Gas Monitoring, Transcutaneous | 1 | 2012 | 34 | 0.100 |
Why?
|
| Premedication | 2 | 2012 | 246 | 0.100 |
Why?
|
| Liver | 1 | 2007 | 7528 | 0.100 |
Why?
|
| Embryonic Development | 1 | 2016 | 721 | 0.090 |
Why?
|
| Growth Disorders | 1 | 1996 | 655 | 0.090 |
Why?
|
| Myocardial Ischemia | 2 | 2008 | 2113 | 0.090 |
Why?
|
| Point-of-Care Systems | 1 | 2020 | 1213 | 0.090 |
Why?
|
| Mammary Arteries | 1 | 1991 | 81 | 0.090 |
Why?
|
| Hospitals | 3 | 2023 | 3883 | 0.090 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 1991 | 177 | 0.090 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2012 | 242 | 0.090 |
Why?
|
| Congresses as Topic | 1 | 2016 | 803 | 0.090 |
Why?
|
| Prospective Studies | 15 | 2019 | 54423 | 0.090 |
Why?
|
| Chronic Disease | 2 | 2022 | 9319 | 0.090 |
Why?
|
| Regional Blood Flow | 2 | 2010 | 1496 | 0.090 |
Why?
|
| Extremities | 1 | 2016 | 867 | 0.090 |
Why?
|
| Education, Medical, Continuing | 1 | 2016 | 823 | 0.090 |
Why?
|
| Odds Ratio | 4 | 2016 | 9647 | 0.090 |
Why?
|
| Anesthesia, Inhalation | 2 | 1992 | 220 | 0.090 |
Why?
|
| Vascular Resistance | 3 | 2019 | 930 | 0.090 |
Why?
|
| Exercise Tolerance | 1 | 2015 | 836 | 0.090 |
Why?
|
| Nitric Oxide | 1 | 2019 | 2136 | 0.090 |
Why?
|
| Collagen Type VIII | 1 | 2009 | 15 | 0.090 |
Why?
|
| Nursing Records | 1 | 2009 | 30 | 0.090 |
Why?
|
| Triiodothyronine | 2 | 2016 | 493 | 0.080 |
Why?
|
| Heparin Antagonists | 1 | 2009 | 34 | 0.080 |
Why?
|
| Sympathetic Nervous System | 1 | 2012 | 518 | 0.080 |
Why?
|
| Models, Cardiovascular | 1 | 2015 | 981 | 0.080 |
Why?
|
| Prognosis | 4 | 2021 | 29629 | 0.080 |
Why?
|
| Cohort Studies | 7 | 2020 | 41495 | 0.080 |
Why?
|
| Fellowships and Scholarships | 1 | 2018 | 1117 | 0.080 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 1995 | 1241 | 0.080 |
Why?
|
| Klinefelter Syndrome | 1 | 2009 | 47 | 0.080 |
Why?
|
| Reproducibility of Results | 5 | 2020 | 20100 | 0.080 |
Why?
|
| Time Factors | 8 | 2020 | 39969 | 0.080 |
Why?
|
| Patient Participation | 1 | 2018 | 1445 | 0.080 |
Why?
|
| Quality Assurance, Health Care | 2 | 2010 | 2169 | 0.080 |
Why?
|
| Young Adult | 7 | 2023 | 59260 | 0.080 |
Why?
|
| Alcohol Drinking | 1 | 2001 | 4028 | 0.080 |
Why?
|
| Nervous System Malformations | 1 | 2010 | 244 | 0.080 |
Why?
|
| Saphenous Vein | 1 | 1991 | 516 | 0.080 |
Why?
|
| Language | 1 | 2018 | 1543 | 0.080 |
Why?
|
| Blood Pressure | 4 | 2016 | 8481 | 0.080 |
Why?
|
| Echocardiography, Doppler | 2 | 2008 | 897 | 0.080 |
Why?
|
| Platelet Count | 2 | 2009 | 781 | 0.080 |
Why?
|
| Adaptation, Physiological | 1 | 2015 | 1301 | 0.080 |
Why?
|
| Catheterization | 1 | 1994 | 1428 | 0.080 |
Why?
|
| Anesthesia Recovery Period | 2 | 2008 | 155 | 0.080 |
Why?
|
| Platelet Factor 4 | 1 | 2008 | 129 | 0.080 |
Why?
|
| Adenosine Diphosphate | 1 | 2009 | 422 | 0.080 |
Why?
|
| Blood Volume | 1 | 2009 | 547 | 0.070 |
Why?
|
| Venous Thrombosis | 1 | 2017 | 1303 | 0.070 |
Why?
|
| Body Weight | 2 | 2017 | 4618 | 0.070 |
Why?
|
| Pentobarbital | 1 | 2008 | 153 | 0.070 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2012 | 748 | 0.070 |
Why?
|
| Pilot Projects | 2 | 2018 | 8633 | 0.070 |
Why?
|
| Arachidonic Acid | 1 | 2009 | 427 | 0.070 |
Why?
|
| Blood Chemical Analysis | 1 | 2009 | 437 | 0.070 |
Why?
|
| Carbon Dioxide | 1 | 2012 | 1147 | 0.070 |
Why?
|
| Psychomotor Agitation | 1 | 2009 | 305 | 0.070 |
Why?
|
| Ultrasonography | 1 | 2020 | 5971 | 0.070 |
Why?
|
| Sex Chromosome Aberrations | 1 | 2007 | 116 | 0.070 |
Why?
|
| Sepsis | 2 | 2019 | 2585 | 0.070 |
Why?
|
| Motivation | 1 | 2016 | 2006 | 0.070 |
Why?
|
| Catheter Ablation | 1 | 2020 | 2751 | 0.070 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2007 | 189 | 0.070 |
Why?
|
| Craniotomy | 1 | 2010 | 741 | 0.070 |
Why?
|
| Practice Guidelines as Topic | 1 | 2023 | 7391 | 0.070 |
Why?
|
| Postoperative Care | 3 | 2022 | 1468 | 0.070 |
Why?
|
| Analgesics, Opioid | 2 | 2021 | 3808 | 0.060 |
Why?
|
| Patient Selection | 1 | 2018 | 4244 | 0.060 |
Why?
|
| Capnography | 1 | 2006 | 91 | 0.060 |
Why?
|
| Blood Coagulation Disorders | 1 | 2009 | 350 | 0.060 |
Why?
|
| Mitral Valve Stenosis | 1 | 2008 | 341 | 0.060 |
Why?
|
| Anesthesia, Epidural | 1 | 1988 | 233 | 0.060 |
Why?
|
| Ultrasonography, Interventional | 1 | 1994 | 1496 | 0.060 |
Why?
|
| Aspirin | 1 | 2017 | 3133 | 0.060 |
Why?
|
| Electronic Health Records | 1 | 2023 | 4811 | 0.060 |
Why?
|
| ROC Curve | 3 | 2018 | 3578 | 0.060 |
Why?
|
| Infusions, Parenteral | 1 | 1985 | 397 | 0.060 |
Why?
|
| Immunoglobulins | 1 | 2008 | 852 | 0.060 |
Why?
|
| Cyclic AMP | 1 | 2009 | 1463 | 0.060 |
Why?
|
| Risk | 1 | 2017 | 9610 | 0.060 |
Why?
|
| Respiratory Mechanics | 1 | 2009 | 699 | 0.060 |
Why?
|
| Child Behavior | 1 | 2010 | 847 | 0.060 |
Why?
|
| Intensive Care Units | 1 | 2018 | 3744 | 0.060 |
Why?
|
| Thrombectomy | 1 | 2010 | 705 | 0.060 |
Why?
|
| Peripheral Arterial Disease | 1 | 2016 | 1273 | 0.060 |
Why?
|
| Calcium | 1 | 1997 | 5722 | 0.060 |
Why?
|
| Ethers | 2 | 1995 | 73 | 0.060 |
Why?
|
| Infant, Small for Gestational Age | 1 | 2007 | 461 | 0.060 |
Why?
|
| Neurofibromatosis 1 | 1 | 2009 | 561 | 0.060 |
Why?
|
| Antibody Formation | 1 | 2008 | 1395 | 0.060 |
Why?
|
| Pulmonary Valve Stenosis | 1 | 2004 | 164 | 0.060 |
Why?
|
| Anxiety | 1 | 2018 | 4573 | 0.050 |
Why?
|
| Prenatal Diagnosis | 1 | 2010 | 1265 | 0.050 |
Why?
|
| Aneurysm | 1 | 1986 | 337 | 0.050 |
Why?
|
| Heart Septal Defects, Ventricular | 2 | 2005 | 477 | 0.050 |
Why?
|
| Ventricular Function, Left | 1 | 2016 | 3879 | 0.050 |
Why?
|
| Myocardium | 1 | 2016 | 4725 | 0.050 |
Why?
|
| Vasodilation | 1 | 2007 | 962 | 0.050 |
Why?
|
| Massachusetts | 1 | 2016 | 8833 | 0.050 |
Why?
|
| Cardiovascular Diseases | 2 | 2019 | 15502 | 0.050 |
Why?
|
| Blood Coagulation Tests | 2 | 2017 | 271 | 0.050 |
Why?
|
| Coronary Stenosis | 1 | 2008 | 794 | 0.050 |
Why?
|
| Health Services Accessibility | 1 | 2020 | 5440 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3086 | 0.050 |
Why?
|
| Anesthesia, Intravenous | 1 | 2003 | 129 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3206 | 0.050 |
Why?
|
| Methyl Ethers | 2 | 1995 | 196 | 0.050 |
Why?
|
| Anesthesia, Local | 1 | 2004 | 277 | 0.050 |
Why?
|
| Heart Rate | 2 | 2016 | 4195 | 0.050 |
Why?
|
| Oxygenators | 1 | 2021 | 36 | 0.050 |
Why?
|
| Ebstein Anomaly | 1 | 2003 | 105 | 0.050 |
Why?
|
| Clinical Trials as Topic | 1 | 2018 | 8002 | 0.050 |
Why?
|
| Heart Atria | 1 | 2008 | 1345 | 0.050 |
Why?
|
| Internship and Residency | 1 | 2022 | 5882 | 0.050 |
Why?
|
| Middle Aged | 11 | 2021 | 220921 | 0.050 |
Why?
|
| Angiography | 1 | 2007 | 1595 | 0.050 |
Why?
|
| Criminal Law | 1 | 2001 | 97 | 0.050 |
Why?
|
| Alprostadil | 1 | 2021 | 86 | 0.050 |
Why?
|
| Sensitivity and Specificity | 1 | 2016 | 14665 | 0.050 |
Why?
|
| Models, Econometric | 1 | 2001 | 216 | 0.050 |
Why?
|
| Xenon | 1 | 2021 | 112 | 0.050 |
Why?
|
| Aorta, Thoracic | 2 | 2023 | 1096 | 0.050 |
Why?
|
| Tuberous Sclerosis | 1 | 2009 | 1030 | 0.050 |
Why?
|
| Ligation | 1 | 2021 | 448 | 0.050 |
Why?
|
| Animals | 5 | 2021 | 168475 | 0.040 |
Why?
|
| Endoscopy | 1 | 2010 | 1851 | 0.040 |
Why?
|
| Quality of Life | 1 | 2022 | 13367 | 0.040 |
Why?
|
| Sampling Studies | 1 | 2001 | 615 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2018 | 6484 | 0.040 |
Why?
|
| Pediatric Nursing | 2 | 2002 | 104 | 0.040 |
Why?
|
| Intracranial Embolism | 1 | 2001 | 189 | 0.040 |
Why?
|
| Radiography | 3 | 2010 | 6965 | 0.040 |
Why?
|
| Fatal Outcome | 1 | 2004 | 1835 | 0.040 |
Why?
|
| Blood Component Transfusion | 1 | 2000 | 142 | 0.040 |
Why?
|
| Heart Neoplasms | 1 | 2002 | 362 | 0.040 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2004 | 628 | 0.040 |
Why?
|
| Computer Simulation | 1 | 2012 | 6241 | 0.040 |
Why?
|
| Hypotension | 1 | 2004 | 879 | 0.040 |
Why?
|
| Radiology, Interventional | 1 | 2002 | 476 | 0.040 |
Why?
|
| Drug Dosage Calculations | 1 | 2019 | 117 | 0.040 |
Why?
|
| American Heart Association | 1 | 2022 | 1039 | 0.040 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 250 | 0.040 |
Why?
|
| Organ Transplantation | 1 | 2008 | 1157 | 0.040 |
Why?
|
| Sternum | 1 | 2018 | 175 | 0.040 |
Why?
|
| Morphine | 1 | 2021 | 657 | 0.040 |
Why?
|
| Chi-Square Distribution | 2 | 2016 | 3415 | 0.040 |
Why?
|
| Aged | 6 | 2021 | 169310 | 0.030 |
Why?
|
| Pharmaceutical Preparations | 1 | 1985 | 1089 | 0.030 |
Why?
|
| Ventricular Septum | 1 | 2017 | 76 | 0.030 |
Why?
|
| Airway Management | 1 | 2020 | 312 | 0.030 |
Why?
|
| Child Nutrition Sciences | 1 | 1996 | 22 | 0.030 |
Why?
|
| Noble Gases | 1 | 2016 | 18 | 0.030 |
Why?
|
| Electrophysiology | 1 | 2020 | 1262 | 0.030 |
Why?
|
| Ketamine | 1 | 2002 | 519 | 0.030 |
Why?
|
| Blalock-Taussig Procedure | 1 | 2016 | 60 | 0.030 |
Why?
|
| Case-Control Studies | 3 | 2021 | 22176 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2020 | 1638 | 0.030 |
Why?
|
| Pulmonary Embolism | 1 | 2010 | 2567 | 0.030 |
Why?
|
| Survival Analysis | 2 | 2020 | 10090 | 0.030 |
Why?
|
| Exercise | 1 | 2012 | 5890 | 0.030 |
Why?
|
| Angiotensin II | 1 | 1979 | 849 | 0.030 |
Why?
|
| Aorta | 1 | 2023 | 2041 | 0.030 |
Why?
|
| Administration, Inhalation | 1 | 2019 | 1157 | 0.030 |
Why?
|
| Critical Illness | 2 | 2020 | 2723 | 0.030 |
Why?
|
| Body Surface Area | 1 | 2016 | 197 | 0.030 |
Why?
|
| Hand | 1 | 2021 | 903 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 58984 | 0.030 |
Why?
|
| Catecholamines | 1 | 2016 | 386 | 0.030 |
Why?
|
| Propofol | 1 | 2021 | 603 | 0.030 |
Why?
|
| Breath Tests | 1 | 2016 | 299 | 0.030 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2020 | 746 | 0.030 |
Why?
|
| Chemoprevention | 1 | 2017 | 326 | 0.030 |
Why?
|
| Communication Barriers | 1 | 2018 | 414 | 0.030 |
Why?
|
| Workflow | 1 | 2019 | 851 | 0.030 |
Why?
|
| Neutrophil Infiltration | 1 | 2017 | 390 | 0.030 |
Why?
|
| Calibration | 1 | 2017 | 818 | 0.030 |
Why?
|
| Antiemetics | 1 | 2016 | 186 | 0.030 |
Why?
|
| Relative Value Scales | 1 | 2014 | 84 | 0.030 |
Why?
|
| Needs Assessment | 1 | 2020 | 1139 | 0.030 |
Why?
|
| Veins | 1 | 2018 | 768 | 0.030 |
Why?
|
| Platelet Aggregation | 1 | 2017 | 771 | 0.030 |
Why?
|
| Hematinics | 1 | 2016 | 282 | 0.030 |
Why?
|
| Patient Transfer | 1 | 2020 | 794 | 0.030 |
Why?
|
| Nutrition Assessment | 1 | 1996 | 728 | 0.030 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2020 | 1352 | 0.030 |
Why?
|
| Infection Control | 1 | 2020 | 982 | 0.030 |
Why?
|
| Diagnosis-Related Groups | 1 | 2014 | 449 | 0.030 |
Why?
|
| Statistics, Nonparametric | 2 | 2009 | 2850 | 0.030 |
Why?
|
| Health Services Needs and Demand | 1 | 2020 | 1403 | 0.030 |
Why?
|
| Respiratory Insufficiency | 1 | 2020 | 1230 | 0.020 |
Why?
|
| Host-Pathogen Interactions | 1 | 2020 | 1459 | 0.020 |
Why?
|
| Dantrolene | 1 | 1991 | 26 | 0.020 |
Why?
|
| Lactic Acid | 1 | 2016 | 1139 | 0.020 |
Why?
|
| Phagocytosis | 1 | 2017 | 1528 | 0.020 |
Why?
|
| Double-Blind Method | 3 | 2006 | 12341 | 0.020 |
Why?
|
| Aortic Valve Insufficiency | 1 | 1995 | 576 | 0.020 |
Why?
|
| Malignant Hyperthermia | 1 | 1991 | 71 | 0.020 |
Why?
|
| Phenylephrine | 1 | 1991 | 293 | 0.020 |
Why?
|
| Aging | 1 | 2010 | 8710 | 0.020 |
Why?
|
| Hemosiderin | 1 | 2010 | 41 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2019 | 4853 | 0.020 |
Why?
|
| Postpartum Period | 1 | 2017 | 1175 | 0.020 |
Why?
|
| Transplantation, Autologous | 1 | 1995 | 2115 | 0.020 |
Why?
|
| Models, Economic | 1 | 2014 | 716 | 0.020 |
Why?
|
| Blood Flow Velocity | 1 | 1994 | 1371 | 0.020 |
Why?
|
| Patient Admission | 1 | 2017 | 1367 | 0.020 |
Why?
|
| Respiration | 1 | 2016 | 1656 | 0.020 |
Why?
|
| Psychomotor Disorders | 1 | 2010 | 149 | 0.020 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2015 | 1164 | 0.020 |
Why?
|
| Norepinephrine | 1 | 1991 | 897 | 0.020 |
Why?
|
| Algorithms | 1 | 2009 | 14033 | 0.020 |
Why?
|
| Swine | 1 | 2018 | 5915 | 0.020 |
Why?
|
| Epinephrine | 1 | 1991 | 792 | 0.020 |
Why?
|
| Neurosurgical Procedures | 1 | 2019 | 2072 | 0.020 |
Why?
|
| Mortality | 1 | 2019 | 2902 | 0.020 |
Why?
|
| Myocardial Revascularization | 1 | 1991 | 790 | 0.020 |
Why?
|
| Decision Making | 1 | 2001 | 3929 | 0.020 |
Why?
|
| Kinetics | 1 | 2015 | 6374 | 0.020 |
Why?
|
| Brain Neoplasms | 1 | 2009 | 9032 | 0.020 |
Why?
|
| Random Allocation | 1 | 1991 | 2395 | 0.020 |
Why?
|
| Pancuronium | 1 | 1986 | 44 | 0.020 |
Why?
|
| Stents | 1 | 2019 | 3179 | 0.020 |
Why?
|
| Thiopental | 1 | 1986 | 55 | 0.020 |
Why?
|
| Factor VIII | 1 | 2009 | 348 | 0.020 |
Why?
|
| Forecasting | 1 | 2015 | 2928 | 0.020 |
Why?
|
| Sex Factors | 1 | 2019 | 10554 | 0.020 |
Why?
|
| Respiratory Tract Diseases | 1 | 2010 | 750 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2016 | 8181 | 0.020 |
Why?
|
| Central Nervous System Diseases | 1 | 2009 | 520 | 0.010 |
Why?
|
| Prevalence | 1 | 2001 | 15733 | 0.010 |
Why?
|
| Oscillometry | 1 | 1984 | 150 | 0.010 |
Why?
|
| Mathematics | 1 | 1985 | 707 | 0.010 |
Why?
|
| Angina Pectoris | 1 | 1988 | 959 | 0.010 |
Why?
|
| Thoracic Injuries | 1 | 1986 | 288 | 0.010 |
Why?
|
| Analysis of Variance | 2 | 2007 | 6228 | 0.010 |
Why?
|
| Factor X | 1 | 2003 | 64 | 0.010 |
Why?
|
| Anastomosis, Surgical | 1 | 2007 | 983 | 0.010 |
Why?
|
| Referral and Consultation | 1 | 1996 | 3600 | 0.010 |
Why?
|
| Plasminogen | 1 | 2003 | 144 | 0.010 |
Why?
|
| Antithrombin III | 1 | 2003 | 128 | 0.010 |
Why?
|
| Organization and Administration | 1 | 2002 | 54 | 0.010 |
Why?
|
| Protein C | 1 | 2003 | 133 | 0.010 |
Why?
|
| Factor VII | 1 | 2003 | 139 | 0.010 |
Why?
|
| Prothrombin | 1 | 2003 | 191 | 0.010 |
Why?
|
| Ventricular Function, Right | 1 | 2007 | 617 | 0.010 |
Why?
|
| Factor V | 1 | 2003 | 167 | 0.010 |
Why?
|
| Nursing Assessment | 1 | 2002 | 106 | 0.010 |
Why?
|
| Credentialing | 1 | 2002 | 116 | 0.010 |
Why?
|
| Perfusion | 1 | 2007 | 1373 | 0.010 |
Why?
|
| Cytokines | 1 | 2017 | 7396 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2017 | 14417 | 0.010 |
Why?
|
| Probability | 1 | 2007 | 2477 | 0.010 |
Why?
|
| Developmental Disabilities | 1 | 2010 | 1509 | 0.010 |
Why?
|
| Injections, Intramuscular | 1 | 2002 | 554 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 26129 | 0.010 |
Why?
|
| Pandemics | 1 | 2020 | 8656 | 0.010 |
Why?
|
| Linear Models | 1 | 2010 | 5872 | 0.010 |
Why?
|
| Rats | 1 | 2016 | 23741 | 0.010 |
Why?
|
| Saralasin | 1 | 1979 | 34 | 0.010 |
Why?
|
| Intraoperative Period | 1 | 2000 | 510 | 0.010 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 1 | 2002 | 494 | 0.010 |
Why?
|
| Radiology Department, Hospital | 1 | 2002 | 406 | 0.010 |
Why?
|
| Hypertension, Renovascular | 1 | 1979 | 116 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2017 | 22174 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 18255 | 0.010 |
Why?
|
| Renin | 1 | 1979 | 641 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1979 | 1625 | 0.010 |
Why?
|
| Reference Values | 1 | 2002 | 4920 | 0.010 |
Why?
|
| Quality of Health Care | 1 | 2009 | 4331 | 0.010 |
Why?
|
| Central Venous Pressure | 1 | 1991 | 79 | 0.010 |
Why?
|
| Patient Care Team | 1 | 2002 | 2521 | 0.010 |
Why?
|
| Registries | 1 | 2007 | 8225 | 0.010 |
Why?
|
| Nausea | 1 | 1992 | 679 | 0.000 |
Why?
|
| Diagnosis, Differential | 1 | 1979 | 12973 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1986 | 20568 | 0.000 |
Why?
|